0.00
Y Mabs Therapeutics Inc (YMAB) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
6.60%
19.52
|
20.90 | 26.50 | 18.46 | 22.80 |
| Cost Of Revenue |
11.30%
2.662
|
3.001 | 7.642 | 2.248 | 3.014 |
| Gross Profit |
5.81%
16.86
|
17.90 | 18.85 | 16.21 | 19.78 |
|
|
8.10%
22.47
|
24.45 | 24.79 | 24.78 | 29.57 |
| Benefits Costs and Expenses |
12.79%
22.76
|
26.09 | 34.04 | 25.11 | 31.95 |
| Costs And Expenses |
8.10%
22.47
|
24.45 | 17.43 | 27.03 | 32.59 |
| Operating Income/Loss |
14.35%
-5.604
|
-6.543 | -5.936 | -8.568 | -9.789 |
| Income/Loss From Continuing Operations Before Tax |
37.74%
-3.232
|
-5.191 | -7.542 | -6.652 | -9.149 |
| Income Tax Expense/Benefit, Current |
40.00%
0.007
|
0.005 | -0.752 | 0.346 | 0.10 |
| Income Tax Expense/Benefit, Deferred |
-
|
- | - | - | - |
| Income Tax Expense/Benefit |
40.00%
0.007
|
0.005 | -0.752 | 0.346 | 0.10 |
| Income/Loss From Continuing Operations After Tax |
37.66%
-3.239
|
-5.196 | -6.79 | -6.998 | -9.249 |
|
|
37.66%
-3.239
|
-5.196 | -6.79 | -6.998 | -9.249 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.47%
45.32
|
45.10 | 0.1838 | 44.63 | 44.02 |
| Diluted Average Shares |
0.47%
45.32
|
45.10 | 0.1838 | 44.63 | 44.02 |
| Basic Earnings Per Share |
41.67%
-0.07
|
-0.12 | -0.15 | -0.16 | -0.21 |
| Diluted Earnings Per Share |
41.67%
-0.07
|
-0.12 | -0.15 | -0.16 | -0.21 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):